Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

By V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, N. Erba, S. Testa, F. Marongiu, E. Bison, G. Denas and 3 more. Journal of Thrombosis and Haemostasis, 2010

604 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Rheumatology, Surgery

View Paper: https://www.semanticscholar.org/paper/3a8cdc7ce44d67b26682aba268db39ab8d0a5bda

Citations in the corpus

• 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (2019, neutral): “138 Patients with SLE with aPL may also receive additional anticoagulant treatment, such as low-molecular weight heparin, during high-risk periods for thrombosis (pregnancy or postoperatively), although no studies have formally addressed this question.”